NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-231-1995-1-AU-06 METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS AU National Stage 39395/93 Abandoned
NCI E-537-1987-2-US-01 GENE FOR DIAGNOSING CANCER METASTATIC POTENTIAL US REISSUE 08/048,136 35097 Expired PDF
NCI E-113-2001-1-US-01 Method of Detecting a Predisposition to Cancer by Detecting a Deletion Polymorphism in The Gene For Human Poly (ADP-ribose) Polymerase US CIP 08/044,618 5449605 Expired PDF
NCI E-231-1995-1-PCT-02 EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION PCT PCT PCT/US1993/002936 Expired
NCI E-231-1995-1-JP-08 METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS JP National Stage 1993-517612 Abandoned
NIMH E-086-1993-0-US-01 GIBBON APE LEUKEMIA VIRUS-BASED RETROVIRAL VECTORS US ORD 08/043,311 Abandoned
NCI E-231-1995-1-ZA-04 METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS ZA ORD 93/02434 Abandoned
NCI E-231-1995-1-IL-03 METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS IL ORD 105326 Abandoned
NIDCR E-063-1993-0-US-01 RECOMBINANT ANTHRAX VACCINES US ORD 08/042,745 Abandoned
NHLBI E-092-1992-0-PCT-02 CONTROL AND/OR PREVENTION OF BINDING OF NF-KB/REL/DORSAL (NRD) FAMILY PROTEINS TO DNA PCT PCT PCT/US1993/003027 Expired
NIDDK E-006-1991-0-US-02 METHOD OF FORMING THREE-STRANDED DNA US FWC 08/041,341 Abandoned
NIAID E-523-1987-1-US-03 ALTERATION OF BIOLOGICAL PROPERTIES OF VACCINIA VIRUS BY INSERTION OF LYMPHOKINE GENES US FWC 08/041,355 Abandoned
NCI E-039-1993-0-US-01 A DETECTION DEVICE AND QUANTITATION METHOD FOR THERAPEUTIC AGENTS IN BLOOD US ORD 08/041,438 5405782 Expired PDF
NIMH E-012-1991-3-US-01 THYMUS PRODUCTION OF MHC PROTEIN US ORD 08/040,681 Abandoned
NIDCR E-176-1992-0-US-01 METHOD OF TREATING ACUTE AND CHRONIC INFLAMMATORY DISEASES US ORD 08/039,849 5449688 Expired PDF
NCI E-071-1992-2-EP-05 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA EP National Stage 93909192.2 Expired
NCI E-071-1992-1-US-01 Nucleic Acid Constructs Containing HIV Genes with Mutated Inhibitory/ Instability Regions and Methods of Using Same US CIP 08/050,478 5972596 Expired PDF
NCI E-071-1992-2-CA-03 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA CA National Stage 2132208 Expired
NCI E-071-1992-2-AU-02 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA AU National Stage 39694/93 Expired
NCI E-151-1989-3-US-02 MATRIX METALLOPROTEINASE INHIBITOR PEPTIDES US FWC 08/039,525 5595885 Expired PDF
NCI E-124-1992-0-PCT-02 USE OF NITRIC OXIDE/NUCLEOPHILE COMPLEXES FOR THE TREATMENT OF CANCER PCT PCT PCT/US1993/002922 Abandoned
NCI E-071-1992-2-PCT-01 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA PCT PCT COMB PCT/US1993/002908 Expired
NCI E-071-1992-2-JP-04 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA JP National Stage 1993-517595 Abandoned
NCI E-071-1992-2-IT-10 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA IT EP 93909192.2 Expired
NCI E-071-1992-2-GB-09 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA GB EP 93909192.2 Expired
NCI E-071-1992-2-BE-06 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA BE EP 93909192.2 Expired
NCI E-071-1992-2-FR-08 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA FR EP 93909192.2 Expired
NCI E-071-1992-2-DE-07 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS FROM mRNA DE EP 93909192.2 Expired
NCI E-185-1993-0-US-01 SUPPRESSION OF HIV EXPRESSION BY ORGANIC THIOPHOSPHATE US ORD 08/037,633 5824664 Expired PDF
NIDDK E-266-1988-1-US-01 CONTRACEPTIVE VACCINE BASED ON ALLOIMMUNIZATION WITH ZONA PELLUCIDA POLYPEPTIDES US CIP 08/038,948 5641487 Expired PDF
NCI E-272-1988-0-US-05 METHOD OF TREATING DISEASES CAUSED BY IMMUNODEFICIENCY STATES BY ADMINISTERING HNCF TO HUMANS US FWC 08/037,548 Abandoned
NIDDK E-173-1990-0-US-04 IN VITRO RETROVIRAL INTEGRATION ASSAY US FWC 08/038,182 Abandoned
NIDCR E-066-1993-0-US-01 BETA-CYSTATHIONASE AND DERIVATIVES THEREOF US ORD 08/038,344 Abandoned
NCI E-113-1993-0-US-01 IN VITRO METHODS FOR ASSESSING THE SUSCEPTIBILITY OF HIV-1-INFECTED INDIVIDUALS TO CYSTEINE PROTEASE-MEDIATED ACTIVATION-INDUCTED... US ORD 08/037,578 5607831 Expired PDF
NCI E-059-1992-0-CA-04 CALANOLIDE ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF CA National Stage 2133080 Expired
NCI E-074-1992-0-CA-06 MIXED LIGAND METAL COMPLEXES OF NITRIC OXIDE NUCLEOPHILE ADDUCTS USEFUL AS CARDIOVASCULAR AGENTS CA National Stage 2132847 Abandoned
NCI E-074-1992-0-JP-13 MIXED LIGAND METAL COMPLEXES OF NITRIC OXIDE NUCLEOPHILE ADDUCTS USEFUL AS CARDIOVASCULAR AGENTS JP National Stage 1993-517541 Abandoned
NCI E-059-1992-0-JP-23 CALANOLIDES, ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF JP National Stage 1993-517559 Expired
NCI E-059-1992-0-LI-17 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF LI EP 93908587.4 Expired
NCI E-059-1992-0-LU-18 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF LU EP 93908587.4 Expired
NCI E-059-1992-0-DK-14 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF DK EP 93908587.4 Expired
NCI E-059-1992-0-ES-08 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF ES EP 93908587.4 Expired
NCI E-059-1992-0-PT-21 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF PT EP 93908587.4 Expired
NCI E-059-1992-0-NL-20 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF NL EP 93908587.4 Expired
NCI E-059-1992-0-MC-19 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF MC EP 93908587.4 Expired
NCI E-059-1992-0-IE-16 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF IE EP 93908587.4 Expired
NCI E-059-1992-0-IT-11 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF IT EP 93908587.4 Expired
NCI E-059-1992-0-GR-15 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF GR EP 3030852 Expired
NCI E-059-1992-0-FR-09 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF FR EP 93908587.4 Expired
NCI E-059-1992-0-DE-07 CALANOLIDES, NOVEL ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF DE EP 93908587.4 Expired